For endometrial carcinoma we can report that clear cell subtypes consisted in equal parts of p53 overexpression/no expression or positive expression and all showed p16 overexpression/no expression while endometrioid subtypes mostly were found to have positive p53 (69.5%) and p16 (69.4%) staining. This evidence concerns the gene CDKN2A and endometrial carcinoma.